Mabtech AB
PrivateLast Round
Buyout/LBO
Mar 1, 2024
Company Overview
Mabtech AB is a biotechnology company that develops, manufactures, and markets monoclonal antibodies, immunoassay kits, and analytical instruments for life science research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mabtech AB Comparables
Compare Mabtech AB with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cellular Technology Limited | 92% | |
| U-CyTech biosciences | 83% | |
| Bio-Techne Corporation | 82% |
Mabtech AB Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Buyout/LBO | Mar 1, 2024 | ||||
| Buyout/LBO | Dec 1, 2019 |
Key People
Founding team and executive leadership
Mabtech AB Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Harmar AB | Buyout/LBO |
| EQT AB | Buyout/LBO |
| IK Partners | Buyout/LBO |
| Mérieux Equity Partners | Buyout/LBO |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 5, 2025
Monthly visitors grew 94% MoM, reaching 44.4K.
- Mar 1, 2024
EQT AB led the buyout round.
Mabtech AB Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Mabtech AB's valuation, stock price, and market status.
Is Mabtech AB a public or private company?
Mabtech AB is a private company.
What is the current stock price of Mabtech AB?
Mabtech AB is a private company with no public stock price. Caplight tracks Mabtech AB's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Mabtech AB worth (valuation)?
Valuation information for Mabtech AB is not publicly available.
Can I buy Mabtech AB stock?
Mabtech AB shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Mabtech AB's last funding round?
Mabtech AB's most recent funding round was Buyout/LBO on March 1, 2024.
Who are the main investors in Mabtech AB?
Key investors in Mabtech AB include EQT AB, IK Partners.
Will Mabtech AB IPO soon?
No public IPO plans have been announced for Mabtech AB.
How can I track Mabtech AB secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Mabtech AB's secondary market activity and sign up for updates.